Cargando…

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study

OBJECTIVE: Pre-eclampsia (PE), a pregnancy-specific syndrome consisting of hypertension and proteinuria occurring de novo after the 20th week of gestation, remains the leading cause of maternal and fetal morbidity and mortality worldwide. Endothelial dysfunction is proposed to be a central feature o...

Descripción completa

Detalles Bibliográficos
Autores principales: Şalk, Sultan, Yurtcu, Nazan, Çetin, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748862/
https://www.ncbi.nlm.nih.gov/pubmed/36511565
http://dx.doi.org/10.4274/tjod.galenos.2022.38932
_version_ 1784849917504651264
author Şalk, Sultan
Yurtcu, Nazan
Çetin, Ali
author_facet Şalk, Sultan
Yurtcu, Nazan
Çetin, Ali
author_sort Şalk, Sultan
collection PubMed
description OBJECTIVE: Pre-eclampsia (PE), a pregnancy-specific syndrome consisting of hypertension and proteinuria occurring de novo after the 20th week of gestation, remains the leading cause of maternal and fetal morbidity and mortality worldwide. Endothelial dysfunction is proposed to be a central feature of the pathophysiology of preeclampsia. However, the mechanism by which this endothelial dysfunction occurs remains uncertain. We investigated the predictive and diagnostic value of serum soluble vascular endothelial growth factor receptor-1 (VEGFR-1) with by comparison of its prepartum and postpartum serum levels in the management of women with PE. MATERIALS AND METHODS: This prospective case-controlled study was composed of pre-eclamptic (n=44) and normal, healthy pregnant (n=44) women. Blood samples were collected before any intervention at the first antenatal examination of the women in the control group and at the admission of the women to the hospital in the PE group, additionally, from all women in the study groups within six hours of the postpartum period, and used for the serum VEGFR-1 analyses. RESULTS: Within both groups, prepartum serum levels of sVEGFR-1 were higher than postpartum levels (p<0.05). In PE, pre-partum and postpartum serum levels of sVEGFR-1 were higher than levels in the control group (p<0.05). Serum sVEGFR-1 levels of preeclamptic women were positively correlated with the degree of proteinuria (p<0.05, r=0.25), systolic (p<0.05, r=0.25), and diastolic blood pressure (p<0.05, r=0.31). CONCLUSION: These findings seem to point to an involvement of sVEGFR-1 in the pathophysiology of PE. Serum sVEGFR-1 has the potential to be used as a valuable biomarker in the prediction, diagnosis, and risk management of women with subtypes of PE including mild and severe PE, HELLP syndrome, and eclampsia. There is a need to study serum sVEGFR-1 as a biomarker in pregnant women with different subtypes of PE.
format Online
Article
Text
id pubmed-9748862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-97488622022-12-21 Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study Şalk, Sultan Yurtcu, Nazan Çetin, Ali Turk J Obstet Gynecol Clinical Investigation OBJECTIVE: Pre-eclampsia (PE), a pregnancy-specific syndrome consisting of hypertension and proteinuria occurring de novo after the 20th week of gestation, remains the leading cause of maternal and fetal morbidity and mortality worldwide. Endothelial dysfunction is proposed to be a central feature of the pathophysiology of preeclampsia. However, the mechanism by which this endothelial dysfunction occurs remains uncertain. We investigated the predictive and diagnostic value of serum soluble vascular endothelial growth factor receptor-1 (VEGFR-1) with by comparison of its prepartum and postpartum serum levels in the management of women with PE. MATERIALS AND METHODS: This prospective case-controlled study was composed of pre-eclamptic (n=44) and normal, healthy pregnant (n=44) women. Blood samples were collected before any intervention at the first antenatal examination of the women in the control group and at the admission of the women to the hospital in the PE group, additionally, from all women in the study groups within six hours of the postpartum period, and used for the serum VEGFR-1 analyses. RESULTS: Within both groups, prepartum serum levels of sVEGFR-1 were higher than postpartum levels (p<0.05). In PE, pre-partum and postpartum serum levels of sVEGFR-1 were higher than levels in the control group (p<0.05). Serum sVEGFR-1 levels of preeclamptic women were positively correlated with the degree of proteinuria (p<0.05, r=0.25), systolic (p<0.05, r=0.25), and diastolic blood pressure (p<0.05, r=0.31). CONCLUSION: These findings seem to point to an involvement of sVEGFR-1 in the pathophysiology of PE. Serum sVEGFR-1 has the potential to be used as a valuable biomarker in the prediction, diagnosis, and risk management of women with subtypes of PE including mild and severe PE, HELLP syndrome, and eclampsia. There is a need to study serum sVEGFR-1 as a biomarker in pregnant women with different subtypes of PE. Galenos Publishing 2022-12 2022-12-13 /pmc/articles/PMC9748862/ /pubmed/36511565 http://dx.doi.org/10.4274/tjod.galenos.2022.38932 Text en ©Copyright 2022 by Turkish Society of Obstetrics and Gynecology | Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Şalk, Sultan
Yurtcu, Nazan
Çetin, Ali
Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title_full Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title_fullStr Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title_full_unstemmed Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title_short Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
title_sort predictive and diagnostic value of serum svegfr-1 level in women with preeclampsia: a prospective controlled study
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748862/
https://www.ncbi.nlm.nih.gov/pubmed/36511565
http://dx.doi.org/10.4274/tjod.galenos.2022.38932
work_keys_str_mv AT salksultan predictiveanddiagnosticvalueofserumsvegfr1levelinwomenwithpreeclampsiaaprospectivecontrolledstudy
AT yurtcunazan predictiveanddiagnosticvalueofserumsvegfr1levelinwomenwithpreeclampsiaaprospectivecontrolledstudy
AT cetinali predictiveanddiagnosticvalueofserumsvegfr1levelinwomenwithpreeclampsiaaprospectivecontrolledstudy